Product Description

Lamivudine IP 150 mg is a pharmaceutical antiviral formulation developed for the effective management of certain viral infections under medical supervision. The formulation is commonly used as part of comprehensive antiviral treatment programs and plays an important role in supporting long-term viral suppression and disease management. It is widely prescribed in combination with other antiviral medications as recommended by healthcare professionals.

Viral infections can significantly affect immune system function and overall health if not managed appropriately. Effective antiviral therapy helps reduce viral replication, supports immune health, and contributes to improved treatment outcomes. Long-term management and adherence to prescribed therapy are essential for maintaining therapeutic effectiveness and reducing disease progression.

Lamivudine belongs to a class of medicines known as nucleoside reverse transcriptase inhibitors (NRTIs). It works by interfering with the replication process of viruses, helping reduce their ability to multiply within the body. By inhibiting viral replication, Lamivudine helps support viral load control and contributes to comprehensive treatment strategies.

The formulation is commonly used as part of combination antiviral therapy and may be prescribed for long-term treatment depending on individual patient requirements. Regular medical monitoring and adherence to prescribed treatment plans are important for achieving optimal therapeutic outcomes.

Manufactured under stringent WHO-GMP quality standards, the formulation is produced using advanced pharmaceutical technologies and undergoes comprehensive quality testing to ensure safety, efficacy, purity, and pharmaceutical consistency. Every batch is carefully monitored to maintain dependable therapeutic performance and high-quality healthcare standards.

Key Features

• Supports antiviral therapy and viral suppression
• Helps reduce viral replication activity
• Supports long-term disease management
• Reliable and consistent therapeutic performance
• Manufactured under strict WHO-GMP standards
• Produced using advanced pharmaceutical processes
• Quality-assured formulation for safe usage

Uses

• Antiviral treatment support
• Long-term viral infection management
• Combination antiviral therapy programs
• Immune health support under medical supervision

How It Works

Lamivudine works by inhibiting viral replication through interference with the viral genetic replication process. This action helps reduce the ability of viruses to multiply and supports effective antiviral management.

Possible Side Effects

Common side effects may include:

• Headache
• Nausea
• Fatigue
• Dizziness
• Diarrhea
• Stomach discomfort
• General weakness

Patients should seek immediate medical attention if severe allergic reactions, breathing difficulties, liver-related symptoms, or unusual symptoms occur.

Precautions

• Use only under medical supervision
• Follow the prescribed treatment schedule carefully
• Avoid missing doses to maintain therapeutic effectiveness
• Inform your doctor about existing liver, kidney, or other medical conditions
• Do not discontinue treatment without medical advice

Storage Instructions

Store in a cool, dry place away from direct sunlight, heat, and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.

Quality Assurance

Manufactured in WHO-GMP certified facilities, the formulation undergoes stringent quality control procedures and comprehensive testing to ensure safety, efficacy, purity, and dependable therapeutic performance. Each batch is evaluated according to international pharmaceutical standards to maintain consistent quality and reliable patient outcomes.